Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.
PHASE4
SGLT2 antagonists and GLP1 agonists are used since a relatively short perio...
Status
Completed
Location
Abt. für Endokrinologie & Stoffwechsel, Univ. Klin f. Innere Medizin III
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
PHASE3
Study D5553C00002 is a multicenter, randomized, double-blind, placebo-contr...
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
PHASE3
Study D5553C0003 is a 28-week, randomized, double-blind, active-controlled,...